An implantable rat liver tumor model for experimental transarterial chemoembolization therapy and its imaging features

Xin Li, Chuan Sheng Zheng, Gan Sheng Feng, Chen Kai Zhuo, Jun Gong Zhao, Xi Liu

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Aim: To establish an ideal implantable rat liver tumor model for interventional therapy study and examine its angiographic signs and MRI, CT features before and after embolization. Methods: Forty male Wistar rats were implanted with Walker-256 tumor in the left lateral lobe of liver. Digital subtraction angiography (DSA) and transarterial chemoembolization were performed on day 14 after implantation. Native computer tomography (CT, n=8) and native magnetic resonance (MR, n=40) were performed between the day 8 and day 21 after implantation. The radiological morphological characteristics were correlated with histological findings. Results: Successful implantation was achieved in all forty rats, which was confirmed by CT and MRI. MR allowed tumor visualization from day 8 while CT from day 11 after implantation. The tumors were hypodensity on CT, hypointense on MR T1-weighted and hyperintense on T2-weighted. The model closely resembled human hepatocarcinoma in growth pattern and the lesions were rich in vasculature on angiography and got its filling mainly from the hepatic artery. Before therapy, tumor size was 211.9±48.7 mm3. No ascites, satellite liver nodules or lung metastasis were found. One week after therapy, tumor size was 963.6±214.8 mm3 in the control group and 356.5±78.4 mm3 in TACE group. Ascites (4/40), satellite liver nodules (7/40) or lung metastasis (3/40) could be seen on day 21. Conclusion: Walker-256 tumor rat model is suitable for the interventional experiment. CT and MRI are helpful in animal optioning and evaluating experimental results.

Original languageEnglish (US)
Pages (from-to)1035-1039
Number of pages5
JournalWorld Journal of Gastroenterology
Volume8
Issue number6
StatePublished - Dec 2002
Externally publishedYes

Fingerprint

Theoretical Models
Liver
Neoplasms
Walkers
Ascites
Therapeutics
Neoplasm Metastasis
Lung
Digital Subtraction Angiography
Hepatic Artery
Wistar Rats
Angiography
Magnetic Resonance Spectroscopy
Tomography
Control Groups
Growth

ASJC Scopus subject areas

  • Gastroenterology

Cite this

An implantable rat liver tumor model for experimental transarterial chemoembolization therapy and its imaging features. / Li, Xin; Zheng, Chuan Sheng; Feng, Gan Sheng; Zhuo, Chen Kai; Zhao, Jun Gong; Liu, Xi.

In: World Journal of Gastroenterology, Vol. 8, No. 6, 12.2002, p. 1035-1039.

Research output: Contribution to journalArticle

Li, Xin ; Zheng, Chuan Sheng ; Feng, Gan Sheng ; Zhuo, Chen Kai ; Zhao, Jun Gong ; Liu, Xi. / An implantable rat liver tumor model for experimental transarterial chemoembolization therapy and its imaging features. In: World Journal of Gastroenterology. 2002 ; Vol. 8, No. 6. pp. 1035-1039.
@article{dd1afdcf8f6047eb91bf5587cfbcacf4,
title = "An implantable rat liver tumor model for experimental transarterial chemoembolization therapy and its imaging features",
abstract = "Aim: To establish an ideal implantable rat liver tumor model for interventional therapy study and examine its angiographic signs and MRI, CT features before and after embolization. Methods: Forty male Wistar rats were implanted with Walker-256 tumor in the left lateral lobe of liver. Digital subtraction angiography (DSA) and transarterial chemoembolization were performed on day 14 after implantation. Native computer tomography (CT, n=8) and native magnetic resonance (MR, n=40) were performed between the day 8 and day 21 after implantation. The radiological morphological characteristics were correlated with histological findings. Results: Successful implantation was achieved in all forty rats, which was confirmed by CT and MRI. MR allowed tumor visualization from day 8 while CT from day 11 after implantation. The tumors were hypodensity on CT, hypointense on MR T1-weighted and hyperintense on T2-weighted. The model closely resembled human hepatocarcinoma in growth pattern and the lesions were rich in vasculature on angiography and got its filling mainly from the hepatic artery. Before therapy, tumor size was 211.9±48.7 mm3. No ascites, satellite liver nodules or lung metastasis were found. One week after therapy, tumor size was 963.6±214.8 mm3 in the control group and 356.5±78.4 mm3 in TACE group. Ascites (4/40), satellite liver nodules (7/40) or lung metastasis (3/40) could be seen on day 21. Conclusion: Walker-256 tumor rat model is suitable for the interventional experiment. CT and MRI are helpful in animal optioning and evaluating experimental results.",
author = "Xin Li and Zheng, {Chuan Sheng} and Feng, {Gan Sheng} and Zhuo, {Chen Kai} and Zhao, {Jun Gong} and Xi Liu",
year = "2002",
month = "12",
language = "English (US)",
volume = "8",
pages = "1035--1039",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "6",

}

TY - JOUR

T1 - An implantable rat liver tumor model for experimental transarterial chemoembolization therapy and its imaging features

AU - Li, Xin

AU - Zheng, Chuan Sheng

AU - Feng, Gan Sheng

AU - Zhuo, Chen Kai

AU - Zhao, Jun Gong

AU - Liu, Xi

PY - 2002/12

Y1 - 2002/12

N2 - Aim: To establish an ideal implantable rat liver tumor model for interventional therapy study and examine its angiographic signs and MRI, CT features before and after embolization. Methods: Forty male Wistar rats were implanted with Walker-256 tumor in the left lateral lobe of liver. Digital subtraction angiography (DSA) and transarterial chemoembolization were performed on day 14 after implantation. Native computer tomography (CT, n=8) and native magnetic resonance (MR, n=40) were performed between the day 8 and day 21 after implantation. The radiological morphological characteristics were correlated with histological findings. Results: Successful implantation was achieved in all forty rats, which was confirmed by CT and MRI. MR allowed tumor visualization from day 8 while CT from day 11 after implantation. The tumors were hypodensity on CT, hypointense on MR T1-weighted and hyperintense on T2-weighted. The model closely resembled human hepatocarcinoma in growth pattern and the lesions were rich in vasculature on angiography and got its filling mainly from the hepatic artery. Before therapy, tumor size was 211.9±48.7 mm3. No ascites, satellite liver nodules or lung metastasis were found. One week after therapy, tumor size was 963.6±214.8 mm3 in the control group and 356.5±78.4 mm3 in TACE group. Ascites (4/40), satellite liver nodules (7/40) or lung metastasis (3/40) could be seen on day 21. Conclusion: Walker-256 tumor rat model is suitable for the interventional experiment. CT and MRI are helpful in animal optioning and evaluating experimental results.

AB - Aim: To establish an ideal implantable rat liver tumor model for interventional therapy study and examine its angiographic signs and MRI, CT features before and after embolization. Methods: Forty male Wistar rats were implanted with Walker-256 tumor in the left lateral lobe of liver. Digital subtraction angiography (DSA) and transarterial chemoembolization were performed on day 14 after implantation. Native computer tomography (CT, n=8) and native magnetic resonance (MR, n=40) were performed between the day 8 and day 21 after implantation. The radiological morphological characteristics were correlated with histological findings. Results: Successful implantation was achieved in all forty rats, which was confirmed by CT and MRI. MR allowed tumor visualization from day 8 while CT from day 11 after implantation. The tumors were hypodensity on CT, hypointense on MR T1-weighted and hyperintense on T2-weighted. The model closely resembled human hepatocarcinoma in growth pattern and the lesions were rich in vasculature on angiography and got its filling mainly from the hepatic artery. Before therapy, tumor size was 211.9±48.7 mm3. No ascites, satellite liver nodules or lung metastasis were found. One week after therapy, tumor size was 963.6±214.8 mm3 in the control group and 356.5±78.4 mm3 in TACE group. Ascites (4/40), satellite liver nodules (7/40) or lung metastasis (3/40) could be seen on day 21. Conclusion: Walker-256 tumor rat model is suitable for the interventional experiment. CT and MRI are helpful in animal optioning and evaluating experimental results.

UR - http://www.scopus.com/inward/record.url?scp=0036898052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036898052&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 1035

EP - 1039

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 6

ER -